Odonate Therapeutics CEO and leadership

Q: Who is the CEO of Odonate Therapeutics?

The CEO of Odonate Therapeutics is Kevin C. Tang.

Zippia score 4.0

Odonate Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Kevin C. Tang is the Odonate Therapeutics's CEO. Odonate Therapeutics has 153 employees, of which 9 are in a leadership position.

Work at Odonate Therapeutics?

Share your experience

Rate Odonate Therapeutics' leadership communication with employees.

Name & TitleBio

Kevin C. Tang

CEO

Michael S. Hearne

Chief Financial Officer

Michael Hearne is a Chief Financial Officer at Tang Capital Mgmt LLC, Chief Financial Officer at La Jolla Pharmaceutical Company, and Chief Financial Officer at TETRAPHASE PHARMACEUTICALS INC. He has experience at PricewaterhouseCoopers International Ltd and has worked as Partner at Rothstein Kass, Partner at Weaver And Tidwell Llp, and VP:Finance & Accounting at Odonate Therapeutics. Michael attended Brigham Young University (BYU).

Aaron I. Davis

Board Member

Craig A. Johnson

Board Member

Joseph O’Connell

Chief Medical Officer

Joseph O’Connell is a Chief Medical Officer at Odonate Therapeutics.

Robert H. Rosen

Board Member

Stewart M. Kroll

Vice President-Biometrics & Regulator Strategy

Stew Kroll is a Chief Development Officer at LA JOLLA PHARMACEUTICAL CO and Chief Development Officer at Odonate Therapeutics and is based in San Francisco Bay Area. He has worked as Senior Vice President at BIOMETRICS SECURITY TECHNOLOGY INC, Director:Biostatistics at Coulter Pharmaceuticals Inc, and VP:Biostatistics at MOLECULAR TEMPLATES INC.. Stew works or has worked as VP at Threshold Pharmaceuticals. He attended University of California Berkeley.

Thomas Wei

Chief Scientific Officer

Thomas Wei is a Chief Scientific Officer at Odonate Therapeutics.

John Lemkey

Chief Operating Officer

John Lemkey is a Chief Operating Officer at Tang Capital Mgmt LLC, Chief Operating Officer at Private Investment Firm, and Chief Operating Officer at Odonate Therapeutics and is based in San Diego, California. He has worked as Chief Financial Officer at Odonate Therapeutics and Senior Auditor at EY. John studied at University of Southern California between 1999 and 2003 and University of Southern California Marshall School of Business between 1999 and 2003.

Do you work at Odonate Therapeutics?

Does leadership effectively guide Odonate Therapeutics toward its goals?

Odonate Therapeutics jobs

Odonate Therapeutics board members

Name & TitleBio

Kevin C. Tang

CEO

Aaron I. Davis

Board Member

Craig A. Johnson

Board Member

Robert H. Rosen

Board Member

Odonate Therapeutics executives FAQs

Who is the CEO of Odonate Therapeutics?

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Companies
California
San Diego, CA
Odonate Therapeutics
Odonate Therapeutics Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of Odonate Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Odonate Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Odonate Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Odonate Therapeutics. The data presented on this page does not represent the view of Odonate Therapeutics and its employees or that of Zippia.

Odonate Therapeutics may also be known as or be related to ODONATE THERAPEUTICS, INC., Odonate Therapeutics, Odonate Therapeutics Inc and Odonate Therapeutics™.